The majority of pharmaceutical development for COVID-19 has been aimed at vaccines. However, a recent Interesting Engineering article discussed a new pill that treats people once they’ve contracted the virus. The drug is called molnupiravir, and its five-day regimen successfully reduced hospitalizations and deaths linked to COVID-19 by half. If approved for emergency use, the drug, developed by Merck, will be the first oral treatment for the illness and could be a step toward eradicating the pandemic.
New Pill Hopes to Fight COVID-19
Merck & Co. has a new pill that allegedly cuts coronavirus hospitalizations and deaths in half.
Oct 13, 2021
Recommended
Recommended
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Break out of the ordinary: see what’s new in life sciences packaging
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this month to experience a breakthrough for life sciences products.
REGISTER NOW!
